Di Tanna, GL
36  Ergebnisse:
Personensuche X
?
1

Socio-economic difference in purchases of ultra-processed f..:

Coyle, DH ; Huang, L ; Shahid, M...
International Journal of Behavioral Nutrition and Physical Activity.  , 2022
 
?
2

Blood Eosinophils in Chinese COPD Participants and Response..:

Bradbury T ; Di Tanna GL ; Scaria A...
https://www.dovepress.com/blood-eosinophils-in-chinese-copd-participants-and-response-to-treatme-peer-reviewed-fulltext-article-COPD.  , 2022
 
?
5

Renin-Angiotensin System Inhibitors in Patients With COVID-..:

Gnanenthiran SR ; Borghi C ; Burger D...
info:eu-repo/semantics/altIdentifier/pmid/36000426.  , 2022
 
?
7

Canagliflozin Reduces Kidney-Related Adverse Events in Type..:

Heerspink, HJL ; Oshima, M ; Zhang, H...
https://discovery.ucl.ac.uk/id/eprint/10129422/3/Wheeler_CREDENCE%20AKI%20renal%20safety%20MS_AJKD_JJL-69208_R2_Final.pdf.  , 2022
 
?
9

Blood Pressure Effects of Canagliflozin and Clinical Outcom..:

Ye, N ; Jardine, MJ ; Oshima, M...
https://discovery.ucl.ac.uk/id/eprint/10122821/1/379911_0_merged_1590387662.pdf.  , 2021
 
?
10

Systematic Characterization of Defecographic Abnormalities ..:

Grossi, U ; Heinrich, H ; Di Tanna, GL...
https://discovery.ucl.ac.uk/id/eprint/10126537/1/Systematic_Characterization_of_Defecographic.99522.pdf.  , 2021
 
?
13

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin..:

Jardine, MJ ; Zhou, Z ; Mahaffey, KW...
https://discovery.ucl.ac.uk/id/eprint/10098888/3/Wheeler_CREDENCE%20eGFR%20subgroups%20revised%20manuscript_JGL-67625_final%20as%20submitted.pdf.  , 2020
 
1-15